SPRED1 anticorps (N-Term)
Aperçu rapide pour SPRED1 anticorps (N-Term) (ABIN356947)
Antigène
Voir toutes SPRED1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- This antibody detects SPRED1 at N-term.
-
Purification
- Protein A column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
-
Immunogène
- KLH conjugated synthetic peptide selected from the N-terminal region of human SPRED1
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
-
ELISA 1: 1,000. Western blot 1: 50 - 1: 100. Immunohistochemistry 1: 10 - 1: 50.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- SPRED1 (Sprouty-Related, EVH1 Domain Containing 1 (SPRED1))
-
Autre désignation
- SPRED1
-
Sujet
- SPRED1 is a tyrosine kinase substrate that inhibits growth-factor-mediated activation of MAP kinase.Synonyms: EVH1/Sprouty domain containing protein, NFLS, Spred-1, Suppressor of Ras/MAPK activation
-
Poids moléculaire
- 50477 Da
-
ID gène
- 161742, 9606
-
UniProt
- Q7Z699
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Antigène
-